Artelo Biosciences, Inc. Warrant
ARTLW
ARTLW was delisted on the 17th of June, 2024.
3 hedge funds and large institutions have $66K invested in Artelo Biosciences, Inc. Warrant in 2019 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
50% more funds holding
Funds holding: 2 → 3 (+1)
22% less capital invested
Capital invested by funds: $85K → $66K (-$19K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AGM
Alpine Global Management
New York
|
+$10.4K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CH
1
CVI Holdings
Wilmington,
Delaware
| $38K | – | – | – |
|
2
Verition Fund Management
Greenwich,
Connecticut
| $20K | – | – | – |
|
|
AGM
3
Alpine Global Management
New York
| $8K | +$10.4K | +14,100 | New |
|
ARTLW Hedge Fund Activity: Q3 2019 in Review
3 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Artelo Biosciences, Inc. Warrant (ARTLW) for Q3 2019, worth a combined $66K — down 22% from $85K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new ARTLW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Alpine Global Management, opening a new position worth an estimated $10.4K.
- 3 institutional investors held Artelo Biosciences, Inc. Warrant (ARTLW) as of Q3 2019, up from 2 in Q2 2019.
- Funds reported $66K of Artelo Biosciences, Inc. Warrant stock for Q3 2019, down 22% quarter-over-quarter.
- 1 fund opened new Artelo Biosciences, Inc. Warrant positions in Q3 2019 and 0 closed out, a net change of +1 holder.
- The largest Artelo Biosciences, Inc. Warrant buyer in Q3 2019 was Alpine Global Management, an estimated $10.4K added.
Based on aggregated 13F filings for Q3 2019.